Frank C. Sciavolino

Frank C. Sciavolino is the co-founder, president and CSO at Thetis Pharma. Frank has over 50 years of experience in the pharmaceutical industry. Frank has served as a senior advisor for Elm Street Ventures and Max Zeller Soehne AG. Frank was also the EVP of global research and development for Indigene Pharmaceuticals. Prior to that, they were a part of the Commission on C&A Medicine at The White House. Frank started their career at Pfizer Inc in 1967 and served as the VP of research and development for 36 years.

Frank C. Sciavolino's educational career began with a Bachelor of Science in Pharmacy from St. John's University. Frank then went on to earn a Master of Science in Medicinal Chemistry from the University of Michigan. After working as an NIH Postdoctoral Fellow in Organic Chemistry at the University of Illinois Urbana-Champaign, they returned to the University of Michigan to complete their Doctor of Philosophy in Medicinal Chemistry.

They are on a team with Chris Cimarusti - Consultant, API & Synthesis, Michael Van Zandt - Senior CMC Lead, and Robert Guttendorf - Consultant. Frank C. Sciavolino reports to Gary Mathias, Co-Founder, CEO and Director.